A Review on the Pathogenesis, Treatment and Prevention of Peptic Ulcer Disease

Full Article - PDF Review History

Published: 2022-10-10

Page: 312- 326


Reema Yadav *

School of Pharmaceutical Science, Formerly University Institute of Pharmacy, Chhatrapati Shahu Ji Maharaj University, Kanpur, India.

Jay Kumar

School of Pharmaceutical Science, Formerly University Institute of Pharmacy, Chhatrapati Shahu Ji Maharaj University, Kanpur, India.

Abhishek Kumar Singh

School of Pharmaceutical Science, Formerly University Institute of Pharmacy, Chhatrapati Shahu Ji Maharaj University, Kanpur, India.

Anjali Yadav

School of Pharmaceutical Science, Formerly University Institute of Pharmacy, Chhatrapati Shahu Ji Maharaj University, Kanpur, India.

Prakash Chandra Gupta

School of Pharmaceutical Science, Formerly University Institute of Pharmacy, Chhatrapati Shahu Ji Maharaj University, Kanpur, India.

*Author to whom correspondence should be addressed.


Abstract

Peptic ulcer disease, defined as the breakdown of the stomach and/or duodenum's epithelial mucosal barrier, is still a leading source of morbidity and mortality. One of the main etiological factors is H. pylori. using nonsteroidal anti-inflammatory medicines while infected with H.Pylori (NSAIDs). Epigastric Patients frequently experience discomfort, heartburn, reflux symptoms, and nausea. Stomach lining inflammation is a symptom of peptic ulcer disease. The majority of the time, the diagnosis is made after endoscopy of the upper gastrointestinal tract. Ulcer is a prevalent condition that affects people all over the world. Allopathic ulcer treatment has negative health consequences due to unpleasant side effects. Numerous herbal plants and secondary metabolites are now used to treat ulcers.The two most frequent causes of peptic ulcers are infection with Helicobacter pylori or taking non-steroidal anti-inflammatory drugs (NSAIDs), such aspirin. NSAIDs are becoming a more common cause of ulceration, notably ulcers worsened by gastrointestinal (GI) bleeding, as H. pylori infection becomes less common in affluent nations. Only around 15% of people infected with H. pylori develop an ulcer in their lifetime, with the risk being dictated by the virulence of the H. pylori strain, host genetics, and environmental factors (particularly smoking). The inhibition of the gastroprotective cyclooxygenase (COX)-1 enzyme is a major cause of NSAID-induced ulcers.

Keywords: H. pylori, gastroprotective enzyme, diagnosis, prevention, treatment


How to Cite

Yadav, Reema, Jay Kumar, Abhishek Kumar Singh, Anjali Yadav, and Prakash Chandra Gupta. 2022. “A Review on the Pathogenesis, Treatment and Prevention of Peptic Ulcer Disease”. Asian Journal of Medical Principles and Clinical Practice 5 (2):312-26. https://journalajmpcp.com/index.php/AJMPCP/article/view/140.

Downloads

Download data is not yet available.